Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) shares are trading lower by 1.69% to $2.33 Thursday morning, reversing following earlier strength, after the company announced the issuance of U.S.
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular discovery and early ...
ROCKVILLE, Md., Feb. 13, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH) ("SHPH" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on ...
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty ...
An announcement from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH)) is now available. Shuttle Pharmaceuticals Holdings is set to present at the 2024 ThinkEquity Conference, showcasing progress in ...
GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty ...
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients ...
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results